139
Views
1
CrossRef citations to date
0
Altmetric
Retina/Optic Nerve

Association of CFI, IL-8, TF and TFR2 Genetic Polymorphisms with Age-Related Macular Degeneration in a Northeastern Chinese Population

, &
Pages 786-790 | Received 09 Aug 2021, Accepted 03 Jan 2022, Published online: 11 Apr 2022

References

  • Khandhadia S, Cipriani V, Yates JRW, Lotery AJ. Age-related macular degeneration and the complement system. Immunobiology. 2012;217:127–146. doi:10.1016/j.imbio.2011.07.019.
  • Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, Seddon JM. Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet. 2009;17:100–104. doi:10.1038/ejhg.2008.140.
  • Kondo N, Bessho H, Honda S, Negi A. Additional evidence to support the role of a common variant near the complement factor I gene in susceptibility to age-related macular degeneration. Eur J Hum Genet. 2010;18:634–635. doi:10.1038/ejhg.2009.243.
  • Bezci Aygun F, Kadayıfcılar S, Ozgul RK, Eldem B. Complement Factor I Gene Polymorphism in a Turkish Age-Related Macular Degeneration Population. Ophthalmologica. 2020;243:187–194. doi:10.1159/000503327.
  • Hautamäki A, Seitsonen S, Holopainen JM, Moilanen JA, Kivioja J, Onkamo P, Järvelä I, Immonen I. The genetic variant rs4073 A→T of the Interleukin-8 promoter region is associated with the earlier onset of exudative age-related macular degeneration. Acta Ophthalmol. 2015;93:726–733. doi:10.1111/aos.12799.
  • Jonas JB, Tao Y, Neumaier M, Findeisen P. Cytokine concentration in aqueous humour of eyes with exudative age-related macular degeneration. Acta Ophthalmol. 2012;90:e381–388–e388. doi:10.1111/j.1755-3768.2012.02414.x.
  • Ambreen F, Ismail M, Qureshi IZ. Association of gene polymorphism with serum levels of inflammatory and angiogenic factors in Pakistani patients with age-related macular degeneration. Mol Vis. 2015;21:985–999.
  • Wysokinski D, Blasiak J, Dorecka M, Kowalska M, Robaszkiewicz J, Pawlowska E, Szaflik J, Szaflik JP. Variability of the transferrin receptor 2 gene in AMD. Dis Markers. 2014;2014:1–8. 2014:doi:10.1155/2014/507356.
  • Wysokinski D, Danisz K, Blasiak J, Dorecka M, Romaniuk D, Szaflik J, Szaflik JP. An association of transferrin gene polymorphism and serum transferrin levels with age-related macular degeneration. Exp Eye Res. 2013;106:14–23. doi:10.1016/j.exer.2012.10.003.
  • Wysokinski D, Danisz K, Pawlowska E, Dorecka M, Romaniuk D, Robaszkiewicz J, Szaflik M, Szaflik J, Blasiak J, Szaflik JP. Transferrin receptor levels and polymorphism of its gene in age-related macular degeneration. Acta Biochim Pol. 2015;62:177–184. doi:10.18388/abp.2014_843.
  • Wysokinski D, Szaflik J, Sklodowska A, Kolodziejska U, Dorecka M, Romaniuk D, Wozniak K, Blasiak J, Szaflik JP. The A Allele of the -576G > A polymorphism of the transferrin gene is associated with the increased risk of age-related macular degeneration in smokers. Tohoku J Exp Med. 2011;223:253–261. doi:10.1620/tjem.223.253.
  • Mitchell P, Foran S. Age-Related Eye Disease Study severity scale and simplified severity scale for age-related macular degeneration. Arch Ophthalmol. 2005;123:1598–1599. doi:10.1001/archopht.123.11.1598.
  • Seddon JM, Yu Y, Miller EC, Reynolds R, Tan PL, Gowrisankar S, Goldstein JI, Triebwasser M, Anderson HE, Zerbib J, et al. 2013. Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat Genet 45:1366–1370. doi:10.1038/ng.2741.
  • Alexander P, Gibson J, Cree AJ, Ennis S, Lotery AJ. Complement factor i and age-related macular degeneration. Mol Vis. 2014;20:1253–1257.
  • Hautamäki A, Kivioja J, Vavuli S, Kakko S, Savolainen ER, Savolainen MJ, Liinamaa MJ, Seitsonen S, Onkamo P, Järvelä I, et al. Interleukin 8 promoter polymorphism predicts the initial response to bevacizumab treatment for exudative age-related macular degeneration. Retina. 2013;33:1815–1827. doi:10.1097/IAE.0b013e318285cf92.
  • Tsai YY, Lin JM, Wan L, Lin HJ, Tsai Y, Lee CC, Tsai CH, Tsai FJ, Tseng SH. Interleukin gene polymorphisms in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:693–698. doi:10.1167/iovs.07-0125.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.